Austedo XR 30 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FWFYP
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,458
Award facts
- Contract value 100% obligated
- $15,458.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $15,458.21 to supply 30-count bottles of Austedo XR 30 mg tablets, with performance in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order was awarded on October 29, 2025, with an ultimate completion date of October 30, 2025, indicating expedited fulfillment of this pharmaceutical supply need.
Austedo XR is a tetrabenazine-based medication primarily prescribed for the treatment of involuntary movement disorders, including tardive dyskinesia and Huntington's disease chorea, representing a specialized pharmaceutical product within the federal healthcare supply chain. As a major pharmaceutical distributor, AmerisourceBergen regularly fulfills critical medical supply requirements for military and veteran healthcare systems through its comprehensive DLA contract vehicle, which encompasses brand-name medications, generics, vaccines, and specialized medical commodities across multiple therapeutic domains. This delivery order reflects the company's continued role as a key supplier for federal medical procurement and the Defense Health Agency's pharmaceutical needs.
Quick answers
Who was awarded contract SPE2DB26FWFYP?
SPE2DB26FWFYP was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FWFYP worth?
The government has obligated $15,458 on SPE2DB26FWFYP.
Is contract SPE2DB26FWFYP an order under another contract?
Yes. SPE2DB26FWFYP is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB26FWFYP competed?
The extent of competition for SPE2DB26FWFYP was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award